August 2016

 

WORLD VIEW

 

Renaissance for presbyopia


by Neel Desai, MD Refractive Editorial Board member

 
 

Neel Desai, MD

Neel Desai, MD Refractive Editorial Board member

 

While the last decade may be seen as the “Era of refractive cataract surgery,” a proliferation of new technologies and approaches are poised to make the next decade the “Renaissance period for presbyopia.” With the recent explosion of new options for surgeons to offer motivated patients, the ability to customize treatment plans to each patient’s stage in life and visual lifestyle dramatically increases. But the risk of overwhelming a patient with new options and terminology also increases. Now more than ever before, surgeons have a deep obligation to understand the nuances of these technologies, including their ideal inclusion and exclusion criteria, in order to enable a clear, confident, and customized recommendation to their patients. In this issue of EyeWorld, experts review these new approaches, offer advice on patient selection, and help us navigate these new waters with pearls to avoid pitfalls and attain excellent results. Daniel Durrie, MD, and George Waring, MD, who introduced us to the concept of dysfunctional lens syndrome (DLS), lay out a staging paradigm for DLS that gives surgeons an easy way to match patients to a customized visual solution at any stage of life. Using patient age and technologies to quantify optical scatter index, wavefront analysis, and lens densitometry, surgeons can more confidently present options and make clear recommendations.

Elizabeth Yeu, MD, William Trattler, MD, Sumit Garg, MD, and Julie Schallhorn, MD, offer their advice on screening and evaluating patients for eligibility for presbyopia procedures. These experts discuss a screening process to identify pre-existing pathology that might affect eligibility and/or outcomes with various presbyopia procedures, and strategies for managing patients with suboptimal outcomes. John Berdahl, MD, Kendall Donaldson, MD, and Audrey Talley- Rostov, MD, brilliantly explain a philosophy of “starting with a plan to finish” that embodies our commitment to achieving excellent outcomes for every single patient, utilizing any and all means necessary. They offer tips on choosing the right presbyopia-correcting IOL for individual patient needs, as well as assessing anatomical and psychological candidacy. Finally, Preeya Gupta, MD, and Sumit Garg, MD, give us a comprehensive overview of exciting new technologies and approaches to presbyopia that move us beyond the limitations of the old presbyopia options of monovision LASIK/PRK or high-add multifocal IOLs. These leaders review the newly FDA-approved corneal inlays KAMRA and Raindrop and their unique applications and mechanism of action. Looking ahead, we get a preview of technologies on the horizon such as the Presbia Flexivue Microlens, FluidVision accommodating lens, the Tecnis Symfony IOL, the Light Adjustable Lens, and groundbreaking pharmacologic therapies for presbyopia. We may not have da Vinci, Michelangelo, Botticelli, Galileo, or Copernicus among us, but I hope you enjoy as much as I do the insights of our own Renaissance contemporaries in this issue of EyeWorld.

Renaissance period for presbyopia Renaissance period for presbyopia
Ophthalmology News - EyeWorld Magazine
283 110
283 110
,
2017-04-11T05:32:36Z
True, 8